iBio plans to use the offering's net proceeds for general co...
iBio plans to use the offering's net proceeds for general corporate purposes, including R&D and working capital. The funds are expected to extend the company's cash runway through 2025. CEO Martin Brenner thanked healthcare specialist investors for their support.
Press Release: IBio Announces $15.0 Million Private Placement
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3501Followers
0Following
8327Visitors
Follow